VBI Vaccines, Inc. - Ordinary Shares (VBIV): Price and Financial Metrics
VBIV Price/Volume Stats
| Current price | $0.07 | 52-week high | $1.35 |
| Prev. close | $0.13 | 52-week low | $0.06 |
| Day low | $0.06 | Volume | 29,900,200 |
| Day high | $0.09 | Avg. volume | 3,655,737 |
| 50-day MA | $0.57 | Dividend yield | N/A |
| 200-day MA | $0.60 | Market Cap | 1.87M |
VBIV Stock Price Chart Interactive Chart >
VBI Vaccines, Inc. - Ordinary Shares (VBIV) Company Bio
VBI Vaccines Inc. develops vaccine candidates and novel technology platforms in Israel and internationally. It develops products based on eVLP, a platform for the design of enveloped virus-like particle vaccines; and Lipid Particle Vaccines platform, a proprietary formulation and process that allows vaccines and biologics to preserve stability, potency, and safety. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts.
VBIV Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
VBIV Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | -88.51% |
| 3-year | -92.77% |
| 5-year | -96.50% |
| YTD | N/A |
| 2024 | 0.00% |
| 2023 | 50.22% |
| 2022 | -83.29% |
| 2021 | -14.91% |
| 2020 | 99.28% |